| First Author | Graham-Paquin AL | Year | 2023 |
| Journal | Nucleic Acids Res | PubMed ID | 37395395 |
| Mgi Jnum | J:338939 | Mgi Id | MGI:7517634 |
| Doi | 10.1093/nar/gkad540 | Citation | Graham-Paquin AL, et al. (2023) ZMYM2 is essential for methylation of germline genes and active transposons in embryonic development. Nucleic Acids Res 51(14):7314-7329 |
| abstractText | ZMYM2 is a transcriptional repressor whose role in development is largely unexplored. We found that Zmym2-/- mice show embryonic lethality by E10.5. Molecular characterization of Zmym2-/- embryos revealed two distinct defects. First, they fail to undergo DNA methylation and silencing of germline gene promoters, resulting in widespread upregulation of germline genes. Second, they fail to methylate and silence the evolutionarily youngest and most active LINE element subclasses in mice. Zmym2-/- embryos show ubiquitous overexpression of LINE-1 protein as well as aberrant expression of transposon-gene fusion transcripts. ZMYM2 homes to sites of PRC1.6 and TRIM28 complex binding, mediating repression of germline genes and transposons respectively. In the absence of ZMYM2, hypermethylation of histone 3 lysine 4 occurs at target sites, creating a chromatin landscape unfavourable for establishment of DNA methylation. ZMYM2-/- human embryonic stem cells also show aberrant upregulation and demethylation of young LINE elements, indicating a conserved role in repression of active transposons. ZMYM2 is thus an important new factor in DNA methylation patterning in early embryonic development. |
